Centrobill Champions Fully Licensed PIX Payments in Brazil with Competitive Fees
LOS ANGELES, May 22, 2024 /PRNewswire/ -- Today Centrobill announced its offering of fully licensed PIX payments in Brazil in a strategic move to dominate the Brazilian fintech market.
Chris Tisdall, Chief Sales Officer at Centrobill, stated, "With fully licensed PIX payments, we ensure secure and cost-effective transactions, and maximize transactional security. We proactively stay ahead of regulations to handle compliance concerns for our clients, supporting their success."
The PIX payments initiative offers a 24/7 transaction window ensuring immediate processing, consolidating Centrobill as the preferred choice for businesses seeking competitive payment solutions and compliance with strict regulations in Brazil.
About Centrobill Centrobill is at the forefront of payment technology, offering innovative solutions that empower businesses to achieve greater financial agility and growth. By continuously adapting to the needs of the market, Centrobill remains a leading choice for those who value reliability and affordability in their payment processes.
China and Kazakhstan have always supported each other and have always been partners in times of challenges, Chinese President Xi Jinping said in a signed article in the Kazakhstanskaya Pravda newspaper and Kazinform International News Agency on...
H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with $64 billion of capital under management, is pleased to announce that an affiliate has signed a definitive agreement to acquire CGH Group S.A. ("CGH" or the "Company"), a...
Truecaller, the leading global platform for verifying contacts and blocking unwanted communication, is publishing its interim report for January-June on Friday 19 July 2024 at 07.30 CET.
Alan Mamedi, CEO and Odd Bolin, CFO presents the report and...
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...
China and Kazakhstan have always supported each other and have always been partners in times of challenges, Chinese President Xi Jinping said in a signed article in the Kazakhstanskaya Pravda newspaper and Kazinform International News Agency on...
